These results suggest that ZNF668 can serve as a potential tumor-type specific prognostic biomarker, although its significance in some cancers (e.g., DLBC, THCA, THYM) was not independent of clinical covariates in subsequent multivariate Cox analyses (Table S1). This evidence concerns the gene ZNF668 and neoplasm.